Metabolic Brain PET Connectivity.

Brain connectivity FDG Fluorodeoxyglucose Metabolic connectivity Neuroimaging PET

Journal

PET clinics
ISSN: 1879-9809
Titre abrégé: PET Clin
Pays: United States
ID NLM: 101260152

Informations de publication

Date de publication:
30 Oct 2024
Historique:
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 31 10 2024
Statut: aheadofprint

Résumé

This review examines the role of metabolic connectivity based on fluorodeoxyglucose-PET in understanding brain network organization across neurologic disorders, with a focus on neurodegenerative diseases. The article explores key methodologies for metabolic connectivity study and highlights altered connectivity patterns in Alzheimer's, Parkinson's, frontotemporal dementia, and other conditions. It also discusses emerging applications, including single-subject analyses and brain-organ interactions.

Identifiants

pubmed: 39482220
pii: S1556-8598(24)00085-3
doi: 10.1016/j.cpet.2024.09.014
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure TH, EG, MD, AV have nothing to disclose. SPC is supported by #NEXTGENERATIONEU (NGEU) and funded by the Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP), project MNESYS (PE0000006) – A multiscale integrated approach to the study of the nervous system in health and disease (DN. 1553 11.10.2022). IY has Consultant fees from ABX-CRO, Blue Earth Diagnostics, and Pentixapharm, and speaker honoraria from Piramal; and funding from Alzheimer Research Initiative Germany - Federal Ministry of Education and Research Germany (BMBF) - German Research Foundation (DFG).

Auteurs

Tatiana Horowitz (T)

Aix Marseille Univ, Marseille, France; CERIMED, CNRS, Centrale Marseille, Institut Fresnel, Marseille, France; Nuclear Medicine Department, AP-HM, Timone Hospital, Marseille, France. Electronic address: Tatiana.horowitz@univ-amu.fr.

Matthieu Doyen (M)

University of Lorraine, IADI, INSERM U1254, Nancy, France.

Silvia Paola Caminiti (SP)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Igor Yakushev (I)

Department of Nuclear Medicine, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

Antoine Verger (A)

Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, Nancy, France.

Eric Guedj (E)

Aix Marseille Univ, Marseille, France; CERIMED, CNRS, Centrale Marseille, Institut Fresnel, Marseille, France; Nuclear Medicine Department, AP-HM, Timone Hospital, Marseille, France.

Classifications MeSH